• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Inspections, Compliance, Enforcement, and Criminal Investigations

  • Print
  • Share
  • E-mail

Section Contents Menu

Enforcement Actions

Schering Laboratories 21-Jul-99 - DETAIL

Letter Issue Date Company Name Issuing Office Subject
07/21/1999 Schering Laboratories New Jersey District Office Drug Manufacturing Facilities/CMP Regulations for Finished Pharmaceuticals
Persons with disabilities having problems accessing the above pdf file may call 301-827-6567 for assistance